Evidence map›Paper›PMID 30214691›Full record

ArticleOncotarget2018

Correction: Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition.

Aroa Baragaño Raneros, Alfredo Minguela, Ramon M Rodriguez, Enrique Colado, Teresa Bernal, Eduardo Anguita, Adela Vasco Mogorron, Alberto Chaparro Gil, Jose Ramon Vidal-Castiñeira, Leonardo Márquez-Kisinousky and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Risk Factors Affecting Clinical Outcome in Patients with Carbapenem-Resistant K. pneumoniae: A Retrospective Study.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Aroa Baragaño RanerosDepartment of Immunology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Alfredo MinguelaImmunology Service, Instituto Murciano de Investigación Biosanitaria (IMIB), Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Ramon M RodriguezDepartment of Immunology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Enrique ColadoDepartment of Hematology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Teresa BernalDepartment of Hematology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Eduardo AnguitaHematology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Department of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain.
Adela Vasco MogorronImmunology Service, Instituto Murciano de Investigación Biosanitaria (IMIB), Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Alberto Chaparro GilHematology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Department of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain.
Jose Ramon Vidal-CastiñeiraDepartment of Immunology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Leonardo Márquez-KisinouskyDepartment of Immunology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Paula Díaz BulnesDepartment of Immunology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Amelia Martinez MarinHematology Service, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Maria Carmen García GarayHematology Service, Hospital General Universitario Santa Lucía, Cartagena, Murcia, Spain.
Beatriz Suarez-AlvarezDepartment of Immunology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Carlos Lopez-LarreaDepartment of Immunology, Hospital Universitario Central de Asturias, Oviedo, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.18632/oncotarget.16657.].

Identifiers

PMID30214691
PMCPMC6132351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.